Cédric Charrier

1.1k total citations
33 papers, 758 citations indexed

About

Cédric Charrier is a scholar working on Molecular Biology, Oncology and Food Science. According to data from OpenAlex, Cédric Charrier has authored 33 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Food Science. Recurrent topics in Cédric Charrier's work include Peptidase Inhibition and Analysis (7 papers), Probiotics and Fermented Foods (6 papers) and Histone Deacetylase Inhibitors Research (6 papers). Cédric Charrier is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Probiotics and Fermented Foods (6 papers) and Histone Deacetylase Inhibitors Research (6 papers). Cédric Charrier collaborates with scholars based in France, United States and Germany. Cédric Charrier's co-authors include Thomas Clavel, Dirk Haller, Mareike Wenning, Michaël Blaut, Philìppe Bertrand, Harry J. Flint, Petra Louis, Jean‐Pierre Gesson, Joëlle Roche and Annett Braune and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Tetrahedron.

In The Last Decade

Cédric Charrier

32 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cédric Charrier France 17 459 104 93 85 75 33 758
Subhankari Prasad Chakraborty India 17 271 0.6× 78 0.8× 104 1.1× 54 0.6× 50 0.7× 36 930
Mei Cao China 20 436 0.9× 36 0.3× 105 1.1× 52 0.6× 55 0.7× 57 1.1k
Yijing Li China 19 375 0.8× 77 0.7× 60 0.6× 34 0.4× 24 0.3× 60 854
Rabeb Dhouib Australia 16 443 1.0× 90 0.9× 59 0.6× 21 0.2× 85 1.1× 31 845
Serap Derman Türkiye 18 272 0.6× 117 1.1× 97 1.0× 20 0.2× 76 1.0× 52 954
Vanessa Albertina Agertt Brazil 13 191 0.4× 109 1.0× 67 0.7× 50 0.6× 33 0.4× 18 573
Vinoth Kumarasamy Malaysia 17 267 0.6× 50 0.5× 74 0.8× 51 0.6× 145 1.9× 62 1.1k
Hualin Fu China 19 315 0.7× 102 1.0× 109 1.2× 29 0.3× 71 0.9× 64 1.3k
Jyoti Tanwar India 13 309 0.7× 72 0.7× 93 1.0× 26 0.3× 120 1.6× 20 860
Arefeh Seyedarabi Iran 16 345 0.8× 63 0.6× 74 0.8× 69 0.8× 21 0.3× 44 787

Countries citing papers authored by Cédric Charrier

Since Specialization
Citations

This map shows the geographic impact of Cédric Charrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Charrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Charrier more than expected).

Fields of papers citing papers by Cédric Charrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cédric Charrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Charrier. The network helps show where Cédric Charrier may publish in the future.

Co-authorship network of co-authors of Cédric Charrier

This figure shows the co-authorship network connecting the top 25 collaborators of Cédric Charrier. A scholar is included among the top collaborators of Cédric Charrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cédric Charrier. Cédric Charrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, David B., Cédric Charrier, & Stephen Hawser. (2020). Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017. Diagnostic Microbiology and Infectious Disease. 97(1). 115013–115013. 2 indexed citations
2.
Pichowicz, Mark, Andrew J. Ratcliffe, Anne‐Marie Salisbury, et al.. (2018). Design, synthesis and antibacterial properties of pyrimido[4,5-b]indol-8-amine inhibitors of DNA gyrase. Bioorganic & Medicinal Chemistry Letters. 28(17). 2998–3003. 16 indexed citations
3.
Charrier, Cédric, Victoria J. Savage, Thomas P. Duffy, et al.. (2017). Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria. Antimicrobial Agents and Chemotherapy. 61(5). 37 indexed citations
4.
Charrier, Cédric, Anne‐Marie Salisbury, Victoria J. Savage, et al.. (2016). In vitrobiological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases. Journal of Antimicrobial Chemotherapy. 71(10). 2831–2839. 6 indexed citations
5.
Savage, Victoria J., Cédric Charrier, Anne‐Marie Salisbury, et al.. (2016). Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IV. Journal of Antimicrobial Chemotherapy. 71(7). 1905–1913. 22 indexed citations
6.
Savage, Victoria J., Cédric Charrier, Anne‐Marie Salisbury, et al.. (2016). Efficacy of a Novel Tricyclic Topoisomerase Inhibitor in a Murine Model of Neisseria gonorrhoeae Infection. Antimicrobial Agents and Chemotherapy. 60(9). 5592–5594. 7 indexed citations
7.
Charrier, Cédric, et al.. (2014). Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis. Orphanet Journal of Rare Diseases. 9(1). 189–189. 53 indexed citations
8.
Charrier, Cédric, et al.. (2013). A new derivative detected in accelerated ageing of artesunate-amodiaquine fixed dose combination tablets. Journal of Pharmaceutical and Biomedical Analysis. 81-82. 20–26. 5 indexed citations
9.
Hanske, Laura, Cédric Charrier, Michaël Blaut, et al.. (2013). Intestinimonas butyriciproducens gen. nov., sp. nov., a butyrate-producing bacterium from the mouse intestine. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 63(Pt_12). 4606–4612. 84 indexed citations
10.
Clavel, Thomas, Cédric Charrier, Mareike Wenning, & Dirk Haller. (2013). Parvibacter caecicola gen. nov., sp. nov., a bacterium of the family Coriobacteriaceae isolated from the caecum of a mouse. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 63(Pt_7). 2642–2648. 22 indexed citations
11.
Clavel, Thomas, Cédric Charrier, & Dirk Haller. (2012). Streptococcus danieliae sp. nov., a novel bacterium isolated from the caecum of a mouse. Archives of Microbiology. 195(1). 43–49. 13 indexed citations
12.
Charrier, Cédric, et al.. (2012). 74 Lynovex®, a novel mucolytic-antimicrobial agent for the treatment of cystic fibrosis. Journal of Cystic Fibrosis. 11. S75–S75. 1 indexed citations
13.
Blanquart, Christophe, Mathias François, Cédric Charrier, Philìppe Bertrand, & Marie-Chantal Grégoire. (2011). Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds. Current Cancer Drug Targets. 11(8). 919–928. 18 indexed citations
14.
Clavel, Thomas, et al.. (2010). Isolation of bacteria from mouse caecal samples and description of Bacteroides sartorii sp. nov. Archives of Microbiology. 192(6). 427–435. 16 indexed citations
15.
16.
Clavel, Thomas, Cédric Charrier, Annett Braune, et al.. (2009). Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov.. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 59(7). 1805–1812. 80 indexed citations
17.
Charrier, Cédric, Jonathan Clarhaut, Jean‐Pierre Gesson, et al.. (2009). Synthesis and Modeling of New Benzofuranone Histone Deacetylase Inhibitors that Stimulate Tumor Suppressor Gene Expression. Journal of Medicinal Chemistry. 52(9). 3112–3115. 41 indexed citations
18.
Louis, Petra, Sheila I. McCrae, Cédric Charrier, & Harry J. Flint. (2007). Organization of butyrate synthetic genes in human colonic bacteria: phylogenetic conservation and horizontal gene transfer. FEMS Microbiology Letters. 269(2). 240–247. 44 indexed citations
19.
Charrier, Cédric, Joëlle Roche, Jean‐Pierre Gesson, & Philìppe Bertrand. (2007). Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analogues. Bioorganic & Medicinal Chemistry Letters. 17(22). 6142–6146. 15 indexed citations
20.
Charrier, Cédric, Philìppe Bertrand, Jean‐Pierre Gesson, & Joëlle Roche. (2006). Synthesis of rigid trichostatin A analogs as HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(20). 5339–5344. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Subhankari Prasad Chakraborty Breakdown of academic impact, for papers by Mei Cao Breakdown of academic impact, for papers by Yijing Li Breakdown of academic impact, for papers by Rabeb Dhouib Breakdown of academic impact, for papers by Serap Derman Breakdown of academic impact, for papers by Vanessa Albertina Agertt Breakdown of academic impact, for papers by Vinoth Kumarasamy Breakdown of academic impact, for papers by Hualin Fu Breakdown of academic impact, for papers by Jyoti Tanwar Breakdown of academic impact, for papers by Arefeh Seyedarabi
Rankless by CCL
2026